A
Arrivo BioVentures
Pharmaceutical development company which focuses on identifying biologics and molecules to improve patient care
About Arrivo BioVentures
Arrivo BioVentures, LLC is a privately held biopharmaceutical company dedicated to the rapid development of biologics and small molecules aimed at enhancing patient outcomes. The company operates within the pharmaceutical and biotech sectors, primarily serving Pharma Biotech companies that seek alternative methods to expand their pipelines and fund development programs in a capital-constrained environment. Arrivo BioVentures leverages the extensive expertise of its seasoned pharmaceutical and startup professionals to expedite drug development processes, whether it involves reformulating existing products or developing new chemical entities. The company’s business model revolves around in-licensing or acquiring promising drug development projects and funding their progression through clinical stages. Revenue is generated through strategic partnerships, licensing agreements, and potential future sales of successfully developed drugs. Arrivo BioVentures is well-positioned to meet the evolving needs of its clients by providing high-quality, efficient, and fast drug development solutions.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Nov 2023 | $45M | $245M | Rex Health Ventures · Solas BioVentures · Orlando Health Ventures | ↗ |
| SERIES AOther financing | May 2016 | $49M | $196M | Jazz Pharmaceuticals · Rex Health Ventures | — |
Growth signals
Latest recorded traffic for Arrivo BioVentures is 1.1K monthly website visits, down 26.7% over the last three months. Arrivo BioVentures's team grew 7.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Arrivo BioVentures in the Cary ecosystem
The Arrivo BioVentures office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Jazz Pharmaceuticals
Rex Health Ventures
Solas BioVentures
Orlando Health Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Arrivo BioVentures on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Arrivo BioVentures’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







